FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087043303> ?p ?o ?g. }

• W2087043303 endingPage "10845" @default.
• W2087043303 startingPage "10841" @default.
• W2087043303 abstract "Extending the productive lifespan of human cells could have major implications for diseases of aging, such as atherosclerosis. We identified a relationship between aging of human vascular smooth muscle cells (SMCs) and nicotinamide phosphoribosyltransferase (Nampt/PBEF/Visfatin), the rate-limiting enzyme for NAD+ salvage from nicotinamide. Replicative senescence of SMCs was preceded by a marked decline in the expression and activity of Nampt. Furthermore, reducing Nampt activity with the antagonist FK866 induced premature senescence in SMCs, assessed by serial quantification of the proportion of cells with senescence-associated β-galactosidase activity. In contrast, introducing the Nampt gene into aging human SMCs delayed senescence and substantially lengthened cell lifespan, together with enhanced resistance to oxidative stress. Nampt-mediated SMC lifespan extension was associated with increased activity of the NAD+-dependent longevity enzyme SIRT1 and was abrogated in Nampt-overexpressing cells transduced with a dominant-negative form of SIRT1 (H363Y). Nampt overexpression also reduced the fraction of p53 that was acetylated on lysine 382, a target of SIRT1, suppressed an age-related increase in p53 expression, and increased the rate of p53 degradation. Moreover, add-back of p53 with recombinant adenovirus blocked the anti-aging effects of Nampt. These data indicate that Nampt is a longevity protein that can add stress-resistant life to human SMCs by optimizing SIRT1-mediated p53 degradation. Extending the productive lifespan of human cells could have major implications for diseases of aging, such as atherosclerosis. We identified a relationship between aging of human vascular smooth muscle cells (SMCs) and nicotinamide phosphoribosyltransferase (Nampt/PBEF/Visfatin), the rate-limiting enzyme for NAD+ salvage from nicotinamide. Replicative senescence of SMCs was preceded by a marked decline in the expression and activity of Nampt. Furthermore, reducing Nampt activity with the antagonist FK866 induced premature senescence in SMCs, assessed by serial quantification of the proportion of cells with senescence-associated β-galactosidase activity. In contrast, introducing the Nampt gene into aging human SMCs delayed senescence and substantially lengthened cell lifespan, together with enhanced resistance to oxidative stress. Nampt-mediated SMC lifespan extension was associated with increased activity of the NAD+-dependent longevity enzyme SIRT1 and was abrogated in Nampt-overexpressing cells transduced with a dominant-negative form of SIRT1 (H363Y). Nampt overexpression also reduced the fraction of p53 that was acetylated on lysine 382, a target of SIRT1, suppressed an age-related increase in p53 expression, and increased the rate of p53 degradation. Moreover, add-back of p53 with recombinant adenovirus blocked the anti-aging effects of Nampt. These data indicate that Nampt is a longevity protein that can add stress-resistant life to human SMCs by optimizing SIRT1-mediated p53 degradation. Age is the greatest risk factor for myocardial infarctions and strokes (1Lakatta E.G. Levy D. Circulation. 2003; 107: 139-146Crossref PubMed Scopus (1673) Google Scholar). This risk is partly attributable to an age-related decline in the ability of vascular cells to resist stress and effectively remodel the arterial wall. Vascular smooth muscle cells (SMCs) 3The abbreviations used are: SMC, smooth muscle cell; Nampt, nicotinamide phosphoribosyltransferase; TSA, trichostatin A; FBS, fetal bovine serum; SA β-Gal, senescence-associated β-galactosidase; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; ANOVA, analysis of variance. 3The abbreviations used are: SMC, smooth muscle cell; Nampt, nicotinamide phosphoribosyltransferase; TSA, trichostatin A; FBS, fetal bovine serum; SA β-Gal, senescence-associated β-galactosidase; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; ANOVA, analysis of variance. are especially important in this regard; the efficiency with which SMCs stabilize a developing atherosclerotic lesion determines whether the lesion will rupture, a potentially fatal event. Strategies to prevent the premature senescence of SMCs could be a promising approach for reducing vascular disease if molecular targets can be identified. Nicotinamide phosphoribosyltransferase (Nampt, also known as Pre-B-cell colony-enhancing factor and Visfatin (2Fukuhara A. Matsuda M. Nishizawa M. Segawa K. Tanaka M. Kishimoto K. Matsuki Y. Murakami M. Ichisaka T. Murakami H. Watanabe E. Takagi T. Akiyoshi M. Ohtsubo T. Kihara S. Yamashita S. Makishima M. Funahashi T. Yamanaka S. Hiramatsu R. Matsuzawa Y. Shimomura I. Science. 2005; 307: 426-430Crossref PubMed Scopus (1653) Google Scholar)) is the rate-limiting enzyme for NAD+ biosynthesis from nicotinamide. The intracellular levels of NAD+ and nicotinamide have recently been identified as important for certain cell survival reactions, including those linked to the sirtuin family of protein deacetylases (3Bitterman K.J. Anderson R.M. Cohen H.Y. Latorre-Esteves M. Sinclair D.A. J. Biol. Chem. 2002; 277: 45099-45107Abstract Full Text Full Text PDF PubMed Scopus (811) Google Scholar, 4Araki T. Sasaki Y. Milbrandt J. Science. 2004; 305: 1010-1013Crossref PubMed Scopus (909) Google Scholar). Sirtuins, such as Sir2 and its mammalian homolog SIRT1, consume NAD+ and generate nicotinamide as they hydrolytically remove a targeted acetyl group (3Bitterman K.J. Anderson R.M. Cohen H.Y. Latorre-Esteves M. Sinclair D.A. J. Biol. Chem. 2002; 277: 45099-45107Abstract Full Text Full Text PDF PubMed Scopus (811) Google Scholar). Nicotinamide is a known inhibitor of NAD+-dependent deacetylation reactions. Therefore, pathways that both replenish NAD+ and clear nicotinamide could be vital to SIRT1 activity. Recently, we discovered that Nampt was substantially up-regulated when a uniquely long-lived human vascular SMC line was subjected to the stress of complete serum withdrawal (5van der Veer E. Nong Z. O'Neil C. Urquhart B. Freeman D. Pickering J.G. Circ. Res. 2005; 97: 25-34Crossref PubMed Scopus (174) Google Scholar). Here, we report that Nampt is a longevity protein that extends the lifespan of human SMCs by activating SIRT1 and restraining the accumulation of p53. Cell Culture—Experiments were performed using primary human vascular SMCs derived by outgrowth from fragments of internal thoracic artery and the HITC6 SMC clonal line, also originally generated from the human internal thoracic artery (6Li S. Fan Y.S. Chow L.H. Van Den Diepstraten C. van Der Veer E. Sims S.M. Pickering J.G. Circ. Res. 2001; 89: 517-525Crossref PubMed Scopus (125) Google Scholar). Dermal fibroblasts from an individual with Hutchison-Gilford progeria syndrome were obtained from the Coriell Cell Repository. To quantify replication, cells were plated at 4,500 cells/cm2, and growth medium with 10% FBS was changed every 2 days until cells reached 90–95% confluence. Harvested cells were counted from triplicate plates, and the number of population doublings was calculated based on: log10 [(number of cells harvested) – log10 (number of cells seeded)]/log10 (2Fukuhara A. Matsuda M. Nishizawa M. Segawa K. Tanaka M. Kishimoto K. Matsuki Y. Murakami M. Ichisaka T. Murakami H. Watanabe E. Takagi T. Akiyoshi M. Ohtsubo T. Kihara S. Yamashita S. Makishima M. Funahashi T. Yamanaka S. Hiramatsu R. Matsuzawa Y. Shimomura I. Science. 2005; 307: 426-430Crossref PubMed Scopus (1653) Google Scholar). Population growth curves were compared using nonlinear regression. Recombinant Retrovirus and Adenovirus Infection—A retroviral gene delivery system was used to generate human cells stably overexpressing Nampt, using methods described previously (7Rocnik E.F. Van Der Veer E. Cao H. Hegele R.A. Pickering J.G. J. Biol. Chem. 2002; 277: 38571-38578Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar). Retrovirus containing pQCXIP-Nampt-IRES-PURO or pQCXIP-IRES-PURO (Clontech Laboratories) was generated by calcium phosphate-mediated transfection of the Phoenix-amphotropic retrovirus packaging cell line (ATCC, Manassas, VA). Stable transductants were selected with puromycin (3 μg/ml). Dominant-negative SIRT1 (H363Y) was similarly transduced using the pBABE retroviral expression vector. Recombinant adenoviral vectors carrying human p53 or enhanced green fluorescent protein expression cassettes were constructed, purified, and titered as described previously (8Cregan S.P. MacLaurin J. Gendron T.F. Callaghan S.M. Park D.S. Parks R.J. Graham F.L. Morley P. Slack R.S. Gene Ther. 2000; 7: 1200-1209Crossref PubMed Scopus (39) Google Scholar). Experiments were performed at a multiplicity of infection of 100 plaque-forming units/cell. Western Blot and Immunoprecipitation Analysis—Protein expression was assessed by Western blot analysis with chemiluminescence detection, as described (7Rocnik E.F. Van Der Veer E. Cao H. Hegele R.A. Pickering J.G. J. Biol. Chem. 2002; 277: 38571-38578Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar). Nampt was detected using a rabbit polyclonal anti-human Nampt/Pre-B-cell colony-enhancing factor antibody (Bethyl Laboratories, Montgomery, TX). SIRT1 was detected using a rabbit polyclonal anti-Sirt1 antibody (Abcam, Cambridge, MA), and p53 and α-tubulin were detected with monoclonal antibodies (DO-1 from Santa Cruz Biotechnology, Santa Cruz, CA and Clone B-5-1-1 from Sigma, respectively). Cytoplasmic p53 was similarly assessed following cell fractionation (NucBuster, Novagen, Minneapolis, MN). Identification of p53 that underwent NAD+-dependent removal of an acetyl group on residue Lys-382 was determined by pretreating SMCs for 2 h with 5 μm trichostatin A (TSA), immunoprecipitating p53 with a goat polyclonal antibody (R&D Systems, Minneapolis, MN), and immunoblotting using a rabbit polyclonal anti-acetylated p53 (Lys-382) antibody (American Proteomics, Carlsbad, CA) and horseradish peroxidase-labeled donkey anti-rabbit IgG antibody (Amersham Biosciences). Nampt Activity—Whole cell lysates were reacted with 5 μm [carbonyl-14C]nicotinamide (Sigma) and 0.5 mm phosphoribosylpyrophosphate in 10 mm NaH2PO4/Na2HPO4 buffer, pH 8.8 (9Rongvaux A. Shea R.J. Mulks M.H. Gigot D. Urbain J. Leo O. Andris F. Eur. J. Immunol. 2002; 32: 3225-3234Crossref PubMed Scopus (476) Google Scholar). Labeled acetone-precipitable nicotinamide mononucleotide was quantified by scintillation counting. Senescence-associated β-Galactosidase Activity Assay—SMCs at ∼70% confluence were fixed in 2% formaldehyde/0.2% glutaraldehyde in phosphate-buffered saline for 3 min and incubated with X-gal-containing reaction mixture, as described (10Dimri G.P. Lee X. Basile G. Acosta M. Scott G. Roskelley C. Medrano E.E. Linskens M. Rubelj I. Pereira-Smith O. Peacocke M. Campisi J. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 9363-9367Crossref PubMed Scopus (5707) Google Scholar). Cells were stained with Hoechst 33258 (2.5 μg/ml), and the proportion of senescence-associated β-galactosidase (SA β-Gal)-positive cells was quantified (Olympus BX51, ×20 objective, ∼1200 cells). Senescence-free survival was determined using Kaplan-Meier analysis of survival versus replicative age. In Vivo Assessment of SIRT1 DeacetylaseActivity—Cell-basedassessment of SIRT1 enzymatic activity was performed using the Fluor de Lys-SIRT1 substrate (Biomol, Plymouth Meeting, PA), as described (11de Boer V.C. de Goffau M.C. Arts I.C. Hollman P.C. Keijer J. Mech. Ageing Dev. 2006; 127: 618-627Crossref PubMed Scopus (145) Google Scholar). SMCs in phenol red-free M199 with 5% FBS were incubated for 2 h with 5 μm TSA followed by the addition of the fluorogenic substrate for 4 h. Signal was quantified by spectrofluorometry (Wallac, Wellesley, MA) and normalized to total protein content. Time-lapse Analysis of SMC Response to Oxidative Stress—The morphologic response to oxidative stress was dynamically assessed by digital time-lapse microscopy, using methods previously described (12Fera E. O'Neil C. Lee W. Li S. Pickering J.G. J. Biol. Chem. 2004; 279: 35573-35582Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar). Hoffman-modulated contrast images (Axiovert S100; Carl Zeiss, Inc. Thornwood, NY) were digitally acquired every 5 min over 3 h, beginning immediately after the addition of 150 μm H2O2 to SMCs in M199 containing 1% FBS. Nampt Expression and Activity Decline as Human SMCs Undergo Replicative Aging—To track Nampt expression as SMCs undergo replicative aging, two human SMC preparations with different in vitro lifespans were studied: 1) primary cultures of SMCs, initiated by outgrowth from the internal thoracic artery harvested from adult patients undergoing coronary artery bypass surgery; and 2) a clonal line of human SMCs (HITC6) that also originated from the internal thoracic artery but displayed enhanced longevity in culture (6Li S. Fan Y.S. Chow L.H. Van Den Diepstraten C. van Der Veer E. Sims S.M. Pickering J.G. Circ. Res. 2001; 89: 517-525Crossref PubMed Scopus (125) Google Scholar). SMCs were serially subcultured until they reached senescence, indicated by cessation of proliferation, an enlarged flattened morphology, and cytoplasmic β-galactosidase activity at pH 6.0 (Fig. 1, A and B). In both SMC preparations, Nampt protein expression declined significantly as SMCs approached senescence (Fig. 1, C and D). Nampt enzyme activity, assessed by quantifying the conversion of nicotinamide to nicotinamide mononucleotide (5van der Veer E. Nong Z. O'Neil C. Urquhart B. Freeman D. Pickering J.G. Circ. Res. 2005; 97: 25-34Crossref PubMed Scopus (174) Google Scholar), fell in presenescent SMCs even more strikingly than Nampt expression, reaching 14 ± 3% (mean ± S.D., n = 3) of basal activity (Fig. 1C). These findings identify the regeneration of NAD+ from nicotinamide as a metabolic pathway that becomes exhausted as SMCs approach senescence. Nampt Regulates and Extends Human Cellular Lifespan—To determine whether human SMC lifespan could be extended by overriding this innate decline in Nampt expression and activity, we augmented Nampt gene dosage by introducing human Nampt cDNA into SMCs using retrovirus. This yielded a 7.1 ± 3.1-fold increase in Nampt activity in stably transduced SMCs. Primary adult SMCs overexpressing Nampt surpassed the maximal lifespan of vector-infected SMCs by an additional 2.1 ± 0.3 population doublings, which, given their otherwise short in vitro lifespan, constituted a 34 ± 4% prolongation of lifespan (Fig. 2A). Equally notably, this extension proceeded in cells that were already well advanced along their path to replicative senescence. In the longer lived HITC6 SMCs, lifespan extension by Nampt was even more striking, with an additional 6.3 ± 0.3 population doublings or a 71 ± 7% extension of lifespan (Fig. 2A). Cell lifespan extension by Nampt was not limited to SMCs and was also seen with human fibroblasts derived from a subject with Hutchinson-Gilford progeria syndrome, a condition associated with markedly premature atherosclerosis (13Al-Shali K.Z. Hegele R.A. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 1591-1595Crossref PubMed Scopus (42) Google Scholar) (Fig. 2A). To determine the role of endogenous Nampt in SMC lifespan and senescence, SMCs were incubated with the specific Nampt antagonist FK866 (14Hasmann M. Schemainda I. Cancer Res. 2003; 63: 7436-7442PubMed Google Scholar). FK866 is a long, almost linear molecule that binds Nampt from within a narrow tunnel at the Nampt dimer interface, an unusual structural relationship that accounts for its specificity (15Khan J.A. Tao X. Tong L. Nat. Struct. Mol. Biol. 2006; 13: 582-588Crossref PubMed Scopus (203) Google Scholar). We quantified the proportion of senescent SMCs in successive subcultures incubated with 10 nm FK866, a concentration we determined reduced Nampt activity in SMCs to 22 ± 2% of baseline. Kaplan-Meier survival analysis revealed a substantially shortened senescence-free survival of Nampt-inhibited cells SMCs (p < 0.0001) (Fig. 2B). In contrast, there was markedly extended senescence-free survival in Nampt-overexpressing SMCs versus vector-infected cells (p < 0.0001) (Fig. 2C). Therefore, a direct relationship exists between Nampt activity and the number of replication cycles a SMC can undergo before becoming senescent. Together with the age-related decline in Nampt activity, these data firmly establish Nampt as a longevity enzyme for human SMCs. Nampt Postpones Senescence by Activating SIRT1—To explore the mechanism by which Nampt regulates SMC lifespan, we considered that Nampt both stimulates NAD+ production and consumes nicotinamide, positioning this enzyme as a potential regulator of the NAD+-dependent deacetylase, SIRT1 (16Revollo J.R. Grimm A.A. Imai S. J. Biol. Chem. 2004; 279: 50754-50763Abstract Full Text Full Text PDF PubMed Scopus (768) Google Scholar). SIRT1 consumes NAD+, is inhibited by nicotinamide, and mediates lifespan extension of caloric restricted animals (17Cohen H.Y. Lavu S. Bitterman K.J. Hekking B. Imahiyerobo T.A. Miller C. Frye R. Ploegh H. Kessler B.M. Sinclair D.A. Mol. Cell. 2004; 13: 627-638Abstract Full Text Full Text PDF PubMed Scopus (507) Google Scholar). To test whether Nampt could stimulate SIRT1 activity in human SMCs, TSA-independent deacetylation of a fluorogenic SIRT1 substrate (Biomol) was quantified. As shown in Fig. 3A, SMCs overexpressing Nampt had a 86 ± 4% (p = 0.03, n = 4) increase in SIRT1 activity. We were surprised to find that Nampt overexpression also modestly increased abundance of SIRT1 protein (1.3 ± 0.3-fold, p = 0.02), although not enough to fully account for the increased deacetylase activity (Fig. 3B). To determine whether the lifespan extending actions of Nampt were mediated by the increased SIRT1 expression and activity, human SMCs were double-transduced to express Nampt and a dominant-negative form of SIRT1 (H363Y) (18Vaziri H. Dessain S.K. Ng Eaton E. Imai S.I. Frye R.A. Pandita T.K. Guarente L. Weinberg R.A. Cell. 2001; 107: 149-159Abstract Full Text Full Text PDF PubMed Scopus (2288) Google Scholar). This revealed that the extended lifespan conferred by Nampt was abrogated when the SIRT1 H363Y allele was co-expressed (5.4 ± 0.5 versus 0.3 ± 0.3 of additional population doublings, p = 0.003). Furthermore, the reduction in senescent SMCs in late passage (37th subculture) Nampt-overexpressing SMCs (19 ± 2%, p = 0.003) was no longer observed when dominant-negative SIRT1 was coexpressed (p = 0.3), with a relative increase in senescence that was greater than for vector-infected SMCs expressing SIRT1 H363Y (55 ± 12 versus 15 ± 10%, p = 0.01, Fig. 3C). Nampt Enhances p53 Degradation and Exogenous p53 Abrogates Nampt-mediated Inhibition of Senescence—p53 is stabilized by acetylation of Lys-382, and this p53 site is a known target of SIRT1-mediated deacetylation (19Nakamura S. Roth J.A. Mukhopadhyay T. Mol. Cell. Biol. 2000; 20: 9391-9398Crossref PubMed Scopus (161) Google Scholar). p53 promotes aging (20Bauer J.H. Helfand S.L. Aging Cell. 2006; 5: 437-440Crossref PubMed Scopus (68) Google Scholar), and in keeping with this, we found that p53 abundance increased as human SMCs approached replicative senescence (Fig. 3D). However, this age-related increase in p53 was blunted in parallel cultures of SMCs overexpressing Nampt. Furthermore, the fraction of p53 that was acetylated on Lys-382 was substantially lower in Nampt-overexpressing SMCs than in control cells (Fig. 3E). This p53 modification was associated with a significantly increased rate of p53 degradation in Nampt-overexpressing SMCs, as assessed in SMCs incubated with cycloheximide (Fig. 3F). To determine whether altered p53 levels underlay the changes in senescence induced by Nampt, p53 was introduced to SMCs using recombinant adenovirus (9Rongvaux A. Shea R.J. Mulks M.H. Gigot D. Urbain J. Leo O. Andris F. Eur. J. Immunol. 2002; 32: 3225-3234Crossref PubMed Scopus (476) Google Scholar). As shown in Fig. 3G, add-back of p53 to Nampt-overexpressing SMCs abrogated the reduction in senescent SMCs afforded by augmented Nampt activity. Collectively, these findings indicate that Nampt postpones cellular senescence by ensuring ongoing and efficient degradation of p53. Nampt Protects against Oxidative Cell Damage—Finally, using time-lapse microscopy (12Fera E. O'Neil C. Lee W. Li S. Pickering J.G. J. Biol. Chem. 2004; 279: 35573-35582Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar), we established that the additional replicative life conferred by Nampt was associated with a healthy, stress-resistant phenotype. Although vector-infected SMCs responded to 150 μm H2O2 by global retraction of plasma membrane, Nampt-overexpressing SMCs, matched for cumulative population doubling, largely maintained their morphology and ability to migrate (Fig. 4A and supplemental video file). Concurrently, H2O2 induced a rapid increase in cytoplasmic p53 in control SMCs, whereas the response was blunted in Nampt-overexpressing SMCs (Fig. 4B). Our study establishes that a programmed diminution in the capacity to regenerate NAD+ from nicotinamide is a critical precursor of human SMC senescence. Moreover, by enhancing Nampt activity, cellular lifespan can be lengthened, a phenomenon that we observed in human primary SMCs, human clonal SMCs, and fibroblasts derived from a patient with Hutchinson-Gilford progeria syndrome. We further established that this anti-aging phenomenon is mediated by enhanced SIRT1 deacetylase activity that, in turn, holds p53 levels below those which induce senescence. These findings implicate a Nampt-SIRT1-p53 axis as a fundamental determinant of human cell aging. The role of Nampt as a driver of cellular stress resistance and longevity is noteworthy in the context of its expression profile. Nampt is up-regulated by stressful stimuli including infection and proinflammatory cytokines (21Jia S.H. Li Y. Parodo J. Kapus A. Fan L. Rotstein O.D. Marshall J.C. J. Clin. Investig. 2004; 113: 1318-1327Crossref PubMed Scopus (537) Google Scholar). In human SMCs, Nampt expression increased substantially in response to the stress of complete serum removal (5van der Veer E. Nong Z. O'Neil C. Urquhart B. Freeman D. Pickering J.G. Circ. Res. 2005; 97: 25-34Crossref PubMed Scopus (174) Google Scholar). This latter response is reminiscent of the up-regulation of PNC1 in yeast subjected to caloric restriction (22Yang H. Lavu S. Sinclair D.A. Exp. Gerontol. 2006; 41: 718-726Crossref PubMed Scopus (100) Google Scholar). PNC1 encodes a nicotinamide deamidase, and the resulting clearance of nicotinamide is considered to be a protective action that, in yeast, translates the stress of caloric restriction into Sir2-mediated extended longevity (23Anderson R.M. Bitterman K.J. Wood J.G. Medvedik O. Sinclair D.A. Nature. 2003; 423: 181-185Crossref PubMed Scopus (610) Google Scholar). The ability of Nampt to enhance resistance to stress and extend cellular longevity in a SIRT1-dependent manner suggests that Nampt may orchestrate an analogous longevity paradigm in human cells. Our data also suggest, however, that such a protective/longevity response to mild stress would itself be dependent on cellular age. That is, the endogenous decline in Nampt activity that we observed in presenescent cells might underlie a switch in the response to low level stress from lifespan extension to accelerated aging. Cell senescence is strongly implicated in age-related pathologies as well as the recognized decline in tissue regenerative potential with age (24Rando T.A. Nature. 2006; 441: 1080-1086Crossref PubMed Scopus (568) Google Scholar). Vascular SMC senescence, a hallmark of atherosclerotic lesions (25Matthews C. Gorenne I. Scott S. Figg N. Kirkpatrick P. Ritchie A. Goddard M. Bennett M. Circ. Res. 2006; 99: 156-164Crossref PubMed Scopus (454) Google Scholar), can be particularly dangerous because the resulting proinflammatory and nonreparative state can incite lesion disruption and acute vascular occlusion. The current findings identify Nampt as underlying an aging suppression pathway in SMCs, with potential relevance to controlling atherosclerosis and possibly other diseases of aging." @default.
• W2087043303 created "2016-06-24" @default.
• W2087043303 creator A5008586313 @default.
• W2087043303 creator A5026289208 @default.
• W2087043303 creator A5048058576 @default.
• W2087043303 creator A5049108001 @default.
• W2087043303 creator A5064992339 @default.
• W2087043303 creator A5069114255 @default.
• W2087043303 creator A5084367723 @default.
• W2087043303 date "2007-04-01" @default.
• W2087043303 modified "2023-10-18" @default.
• W2087043303 title "Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase" @default.
• W2087043303 cites W1973746592 @default.
• W2087043303 cites W1977397720 @default.
• W2087043303 cites W1997664301 @default.
• W2087043303 cites W2006806054 @default.
• W2087043303 cites W2016894072 @default.
• W2087043303 cites W2029705406 @default.
• W2087043303 cites W2066630518 @default.
• W2087043303 cites W2073988218 @default.
• W2087043303 cites W2094282039 @default.
• W2087043303 cites W2104908670 @default.
• W2087043303 cites W2108536847 @default.
• W2087043303 cites W2118647245 @default.
• W2087043303 cites W2119363024 @default.
• W2087043303 cites W2124595934 @default.
• W2087043303 cites W2126487884 @default.
• W2087043303 cites W2135110328 @default.
• W2087043303 cites W2144424664 @default.
• W2087043303 cites W2146064539 @default.
• W2087043303 cites W2146689062 @default.
• W2087043303 cites W2156712995 @default.
• W2087043303 cites W2159652870 @default.
• W2087043303 cites W2167990179 @default.
• W2087043303 cites W2313495547 @default.
• W2087043303 cites W3015544325 @default.
• W2087043303 doi "https://doi.org/10.1074/jbc.c700018200" @default.
• W2087043303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17307730" @default.
• W2087043303 hasPublicationYear "2007" @default.
• W2087043303 type Work @default.
• W2087043303 sameAs 2087043303 @default.
• W2087043303 citedByCount "289" @default.
• W2087043303 countsByYear W20870433032012 @default.
• W2087043303 countsByYear W20870433032013 @default.
• W2087043303 countsByYear W20870433032014 @default.
• W2087043303 countsByYear W20870433032015 @default.
• W2087043303 countsByYear W20870433032016 @default.
• W2087043303 countsByYear W20870433032017 @default.
• W2087043303 countsByYear W20870433032018 @default.
• W2087043303 countsByYear W20870433032019 @default.
• W2087043303 countsByYear W20870433032020 @default.
• W2087043303 countsByYear W20870433032021 @default.
• W2087043303 countsByYear W20870433032022 @default.
• W2087043303 countsByYear W20870433032023 @default.
• W2087043303 crossrefType "journal-article" @default.
• W2087043303 hasAuthorship W2087043303A5008586313 @default.
• W2087043303 hasAuthorship W2087043303A5026289208 @default.
• W2087043303 hasAuthorship W2087043303A5048058576 @default.
• W2087043303 hasAuthorship W2087043303A5049108001 @default.
• W2087043303 hasAuthorship W2087043303A5064992339 @default.
• W2087043303 hasAuthorship W2087043303A5069114255 @default.
• W2087043303 hasAuthorship W2087043303A5084367723 @default.
• W2087043303 hasBestOaLocation W20870433031 @default.
• W2087043303 hasConcept C181199279 @default.
• W2087043303 hasConcept C185592680 @default.
• W2087043303 hasConcept C199360897 @default.
• W2087043303 hasConcept C2778029271 @default.
• W2087043303 hasConcept C2780391879 @default.
• W2087043303 hasConcept C41008148 @default.
• W2087043303 hasConcept C55493867 @default.
• W2087043303 hasConcept C75520062 @default.
• W2087043303 hasConcept C86803240 @default.
• W2087043303 hasConcept C95444343 @default.
• W2087043303 hasConceptScore W2087043303C181199279 @default.
• W2087043303 hasConceptScore W2087043303C185592680 @default.
• W2087043303 hasConceptScore W2087043303C199360897 @default.
• W2087043303 hasConceptScore W2087043303C2778029271 @default.
• W2087043303 hasConceptScore W2087043303C2780391879 @default.
• W2087043303 hasConceptScore W2087043303C41008148 @default.
• W2087043303 hasConceptScore W2087043303C55493867 @default.
• W2087043303 hasConceptScore W2087043303C75520062 @default.
• W2087043303 hasConceptScore W2087043303C86803240 @default.
• W2087043303 hasConceptScore W2087043303C95444343 @default.
• W2087043303 hasIssue "15" @default.
• W2087043303 hasLocation W20870433031 @default.
• W2087043303 hasOpenAccess W2087043303 @default.
• W2087043303 hasPrimaryLocation W20870433031 @default.
• W2087043303 hasRelatedWork W1641042124 @default.
• W2087043303 hasRelatedWork W1990804418 @default.
• W2087043303 hasRelatedWork W1993764875 @default.
• W2087043303 hasRelatedWork W2013243191 @default.
• W2087043303 hasRelatedWork W2024850262 @default.
• W2087043303 hasRelatedWork W2082860237 @default.
• W2087043303 hasRelatedWork W2117258802 @default.
• W2087043303 hasRelatedWork W2130076355 @default.
• W2087043303 hasRelatedWork W2151865869 @default.
• W2087043303 hasRelatedWork W2392834505 @default.
• W2087043303 hasVolume "282" @default.

• next